Please login to the form below

Not currently logged in
Email:
Password:

KaloBios

This page shows the latest KaloBios news and features for those working in and with pharma, biotech and healthcare.

Post-Shkreli KaloBios pledges transparent pricing

Post-Shkreli KaloBios pledges transparent pricing

KaloBios became embroiled in the furore surrounding the pricing antics of Martin Shkreli last year - subsequently firing him as CEO as a first step on the path to restoring its reputation. ... In the US benznidazole would be made available regardless of

Latest news

  • KaloBios files for bankruptcy protection KaloBios files for bankruptcy protection

    KaloBios' brief moment in the spotlight is approaching an unedifying end after it filed for bankruptcy in the closing hours of 2015. ... It also emerged that KaloBios' former outside counsel Evan Greebel was also under investigation alongside Shkreli in

  • Shkreli fallout claims Turing jobs and KaloBios' listing Shkreli fallout claims Turing jobs and KaloBios' listing

    The repercussions of Martin Shkreli's arrest continue to be felt, with Turing Pharma announcing job cuts and KaloBios facing de-listing from the Nasdaq. ... Trading in KaloBios' shares has been halted since news of Shkreli's arrest emerged.

  • Update: Shkreli resigns as Turing CEO, ousted from KaloBios Update: Shkreli resigns as Turing CEO, ousted from KaloBios

    Shares in KaloBios had been hit hard when news of his arrest broke. ... Shares in KaloBios were hit hard as news of the arrest broke last week.

  • Turing CEO Shkreli arrested by FBI in securities fraud probe Turing CEO Shkreli arrested by FBI in securities fraud probe

    US Attorney Robert Capers said at a press conference yesterday that Shkreli - who has recently been appointed CEO at KaloBios Pharmaceuticals - ran his companies "like a Ponzi scheme, where he used ... Share in KaloBios plummeted and were halted

  • Partner for Sanofi on pneumonia KB001

    KaloBios has announced an agreement with Sanofi Pasteur for the development of KB001 for Pseudomonas aeruginosa (Pa) infections. ... thousands of dollars to the cost of a hospital stay," said Dr Tillman Pearce, chief medical officer of KaloBios.

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest appointments

  • KaloBios names Herb Cross as CFO KaloBios names Herb Cross as CFO

    He joins from Affymax. Herb Cross is to join KaloBios as the company's new chief financial officer. ... David Pritchard, president and CEO of KaloBios, described Cross as a “well respected finance professional with over sixteen years of experience”.

  • V Bryan Lawlis joins board of KaloBios V Bryan Lawlis joins board of KaloBios

    Is co-founder of Itero and Covance. KaloBios has announced that Dr V Bryan Lawlis is to join the company's board of directors. ... patient-targeted, monoclonal antibodies towards commercialisation,” said David Pritchard, president and CEO of KaloBios.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics